期刊文献+

米多君与倍美力治疗女性压力性尿失禁的疗效比较 被引量:4

下载PDF
导出
摘要 目的比较α受体激动剂盐酸米多君和雌激素倍美力治疗女性压力性尿失禁(FSUI)的疗效及安全性。方法54例FSUI患者随机分组,A组30例盐酸米多君2.5mg每日3次口服,B组24例倍美力软膏每晚阴道给药,疗程均为4周。治疗前后测血压、心电图,B超测膀胱残余尿,随访不良事件,做尿垫试验、尿失禁等级评分及自我评价。结果治疗前、后两组间血压、心率均无差异(P>0.05);尿失禁量及两种评分治疗前两组间均无差异(P>0.05),治疗后两组尿失禁量及两种评分均明显降低(P<0.01),且A组较B组更明显(P<0.01)。结论两种药物保守治疗FSUI均有效,盐酸米多君口服疗效更明显。
出处 《江苏医药》 CAS CSCD 北大核心 2007年第4期408-409,共2页 Jiangsu Medical Journal
  • 相关文献

参考文献4

二级参考文献12

  • 1金锡御.尿失禁[A].见:金锡御 宋波 主编.临床尿动力学[C].北京:人民卫生出版社,2002.193—208.
  • 2Coiling J. An update on the AHCPR guideline implementation. Nurse Practice Forum, 1994,5 : 134-137.
  • 3McGuire EJ, Bennett CJ, Konnak JA, et al. Experience with pubovaginal slings for urinary incontinence at the university of Michigan. J Urol, 1987,138:525-529.
  • 4Buckner S ,Milicic I ,Daza A ,et al. ABT-866 ,a novel alpha(1A) -adrenoceptor agonist with antagonist properties at the alpha ( 1B )- andalpha ( 1 D) -adrenoceptor subtypes. Eur J Pharmacol, 2002,449 : 159-165.
  • 5Brune ME, O' Neill AB, Gauvin DM, et al. Comparison of alpha 1-adrenoceptor agonists in canine urethral pressure profilometry and abdominal leak point pressure models. J Urol,2001,166 : 1555-1559.
  • 6Nito H. Clinical effect of midodfine hydrochlofide on the patients with urinary incontinence. Hinyokika Kiyo, 1994,40:91-94.
  • 7Weil EH,Eerdmans PH, Dijkman GA, et al. Randomized double-blind placebo-controlled muhicenter evaluation of efficacy and dose finding of midodrine hydrochloride in women with mild to moderate stress urinary incontinence: a phase Ⅱ study. Int Urogynecol J Pelvic FloorDvsfunct, 1998,9 : 145-150.
  • 8McGuire EJ,Fitzpatrick CC,Wan J,et al. Clinical assessment of urethral sphincter function. J Urol 1993,150:1452-1454.
  • 9Brune ME, O' Neill AB, Gauvin DM, et al. Comparison of alphal-adrenoceptor agonists in canine urethral pressure profilometry and abdominal leak point pressure models. J Urol,2001,166:1555-1559.
  • 10Weil EH, Eerdmans PH, Dijkman GA,et al. Randomized double-blind placebo-controlled multicenter evaluation of efficacy and dose finding of midodrine hydrochloride in women with mild to moderate stress urinary incontinence: a Phase Ⅱ study. Int Urogynecol J Pelvic Floor Dysfunct, 1998,9:145-150.

共引文献33

同被引文献16

引证文献4

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部